Breaking News Instant updates and real-time market news.

GD

General Dynamics

$182.33

5.27 (2.98%)

07:32
04/24/19
04/24
07:32
04/24/19
07:32

General Dynamics reports Q1 EPS $2.56, consensus $2.42

Reports Q1 revenue $9.3B, consensus $8.84B.

  • 24

    Apr

  • 01

    May

  • 29

    May

GD General Dynamics
$182.33

5.27 (2.98%)

02/04/19
BERN
02/04/19
NO CHANGE
Target $178
BERN
Market Perform
General Dynamics price target lowered to $178 from $186 at Bernstein
Bernstein analyst Douglas Harned lowered his price target for General Dynamics to $178 from $186 after the company reported solid Q4 results, but several issues raised more caution for short-term sentiment on the stock. The analyst reiterates a Market Perform rating on the shares.
02/15/19
FBCO
02/15/19
DOWNGRADE
FBCO
Neutral
General Dynamics downgraded to Neutral from Outperform at Credit Suisse
02/15/19
FBCO
02/15/19
DOWNGRADE
Target $184
FBCO
Neutral
General Dynamics downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Robert Springarn downgraded General Dynamics to Neutral from Outperform and lowered his price target to $184 from $190. In a research note to investors, Springarn says the acquisition of CSRA appears to be only "nominally accretive" to 2019, well short of his expectations, and says he believes the acquisition has significantly reduced the company's balance sheet flexibility and may limit future shareholder returns. Additionally, Springarn sees increasing competitive threats in both IT and Aerospace, which dims his growth outlook. Springarn says he is no longer convinced that General Dynamics can outperform, at least until management can show that its strategy warrants a higher multiple.
02/15/19
02/15/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Coca-Cola (KO) downgraded to Neutral from Buy at Citi with analyst Wendy Nicholson saying the company's guidance implies 2019 earnings growth of plus or minus 1%. Coca-Cola has reported earnings per share of $2.00, plus or minus 10c, for the last eight years, with strong underlying growth offset by dilution from refranchising activities and currency headwinds. 2. General Dynamics (GD) downgraded to Neutral from Outperform at Credit Suisse with analyst Robert Springarn saying the acquisition of CSRA appears to be only "nominally accretive" to 2019, well short of his expectations, and says he believes the acquisition has significantly reduced the company's balance sheet flexibility and may limit future shareholder returns. 3. Ball Corp. (BLL) downgraded to Neutral from Buy at UBS with analyst Edlain Rodriguez saying while Ball's fundamentals "remain solid," a higher multiple "is a stretch" with the stock already up 45% over the past year. 4. Six Flags (SIX) downgraded to Sector Weight from Overweight at KeyBanc with analyst Brett Andress saying he remains constructive on the broader theme park industry and the majority of Six Flags' growth pillars, but international upside had been a key component of his thesis and the significantly reduced visibility and potential downside prompts the downgrade. 5. LogMeln (LOGM) downgraded to Perform from Outperform at Oppenheimer and to Hold from Buy at Needham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, Reference Link

TODAY'S FREE FLY STORIES

HTH

Hilltop Holdings

$20.05

0.26 (1.31%)

08:03
06/27/19
06/27
08:03
06/27/19
08:03
Hot Stocks
Hilltop Holdings signs sponsored research agreement with GWU »

Hoth Therapeutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Aug

HQY

HealthEquity

$62.16

-2.5 (-3.87%)

08:03
06/27/19
06/27
08:03
06/27/19
08:03
Conference/Events
HealthEquity to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

ALRN

Aileron Therapeutics

$0.75

-0.0365 (-4.63%)

08:02
06/27/19
06/27
08:02
06/27/19
08:02
Hot Stocks
Aileron Therapeutics announces FDA acceptance of IND for ALRN-6924 »

Aileron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$375.05

5.68 (1.54%)

08:02
06/27/19
06/27
08:02
06/27/19
08:02
Recommendations
Boeing analyst commentary  »

BofA continues to see 6-9…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 24

    Jul

CABO

Cable One

$1,111.46

-18.95 (-1.68%)

08:02
06/27/19
06/27
08:02
06/27/19
08:02
Recommendations
Cable One analyst commentary  »

Cable One price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$85.74

0.32 (0.37%)

08:01
06/27/19
06/27
08:01
06/27/19
08:01
Recommendations
VF Corp. analyst commentary  »

VF Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:00
06/27/19
06/27
08:00
06/27/19
08:00
Options
Tesla put buyer realizes 36% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COUP

Coupa Software

$119.01

-1.3 (-1.08%)

07:57
06/27/19
06/27
07:57
06/27/19
07:57
Recommendations
Coupa Software analyst commentary  »

Coupa Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

BB

BlackBerry

$7.55

-0.74 (-8.93%)

07:56
06/27/19
06/27
07:56
06/27/19
07:56
Recommendations
BlackBerry analyst commentary  »

BlackBerry execution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SM

SM Energy

$12.56

0.63 (5.28%)

07:55
06/27/19
06/27
07:55
06/27/19
07:55
Initiation
SM Energy initiated  »

SM Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

07:55
06/27/19
06/27
07:55
06/27/19
07:55
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

ITRI

Itron

$60.88

0.48 (0.79%)

07:55
06/27/19
06/27
07:55
06/27/19
07:55
Conference/Events
Itron to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

XEC

Cimarex Energy

$57.17

1.64 (2.95%)

07:53
06/27/19
06/27
07:53
06/27/19
07:53
Initiation
Cimarex Energy initiated  »

Cimarex Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

COUP

Coupa Software

$119.01

-1.3 (-1.08%)

07:52
06/27/19
06/27
07:52
06/27/19
07:52
Recommendations
Coupa Software analyst commentary  »

Coupa Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

LECO

Lincoln Electric

$79.77

0.1 (0.13%)

07:52
06/27/19
06/27
07:52
06/27/19
07:52
Downgrade
Lincoln Electric rating change  »

Lincoln Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EV

Eaton Vance

$42.13

0.455 (1.09%)

07:50
06/27/19
06/27
07:50
06/27/19
07:50
Conference/Events
Eaton Vance to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBC

Luther Burbank

$10.33

-0.13 (-1.24%)

07:50
06/27/19
06/27
07:50
06/27/19
07:50
Upgrade
Luther Burbank rating change at Sandler ONeill »

Luther Burbank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QIWI

Qiwi

$20.29

0.54 (2.73%)

07:49
06/27/19
06/27
07:49
06/27/19
07:49
Hot Stocks
Qiwi appoints Vladislav Poshmorga as CFO »

QIWI announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$23.58

-0.24 (-1.01%)

07:48
06/27/19
06/27
07:48
06/27/19
07:48
Upgrade
KB Home rating change  »

KB Home upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIZZ

National Beverage

$42.28

-0.92 (-2.13%)

07:47
06/27/19
06/27
07:47
06/27/19
07:47
Recommendations
National Beverage analyst commentary  »

Guggenheim says National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIVE

Aerohive

$4.44

1.26 (39.62%)

07:46
06/27/19
06/27
07:46
06/27/19
07:46
Downgrade
Aerohive rating change at Craig-Hallum »

Aerohive downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMGN

ImmunoGen

$1.95

0.14 (7.73%)

07:45
06/27/19
06/27
07:45
06/27/19
07:45
Conference/Events
ImmunoGen to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

ACRS

Aclaris Therapeutics

$4.45

0.06 (1.37%)

07:43
06/27/19
06/27
07:43
06/27/19
07:43
Downgrade
Aclaris Therapeutics rating change at SVB Leerink »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLS

Apellis

$23.45

-0.38 (-1.59%)

07:43
06/27/19
06/27
07:43
06/27/19
07:43
Hot Stocks
Apellis complete enrollment of Phase 3 APL-2 head-to-head study »

Apellis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

TRIP

TripAdvisor

$44.04

-0.47 (-1.06%)

07:41
06/27/19
06/27
07:41
06/27/19
07:41
Upgrade
TripAdvisor rating change  »

TripAdvisor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.